IMDAILM: Inferring miRNA-Disease Association by Integrating lncRNA and miRNA Data
暂无分享,去创建一个
Jialiang Yang | Yuhua Yao | Bo Liao | Binbin Ji | Xiaofang Xiao | Sihong Shi | Junlin Xu | Enchao Yu | Bo Liao | Enchao Yu | Yuhua Yao | Jialiang Yang | Junlin Xu | Binbin Ji | Sihong Shi | X. Xiao
[1] Xiangxiang Zeng,et al. Prediction and Validation of Disease Genes Using HeteSim Scores , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[2] Yufei Huang,et al. Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.
[3] X. Yang,et al. Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer. , 2016, European review for medical and pharmacological sciences.
[4] M. Zheng,et al. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer , 2014, Archives of Gynecology and Obstetrics.
[5] S. Brenner,et al. General Nature of the Genetic Code for Proteins , 1961, Nature.
[6] Yu Wang,et al. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1 , 2015, Oncotarget.
[7] Jing Liu,et al. Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] Ning Liu,et al. Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675 , 2014, PloS one.
[9] Michael W Sill,et al. Improved survival with bevacizumab in advanced cervical cancer. , 2014, The New England journal of medicine.
[10] Xia Li,et al. Prediction of potential disease-associated microRNAs based on random walk , 2015, Bioinform..
[11] Alan D. Lopez,et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis , 2011, The Lancet.
[12] Y. Akao,et al. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.
[13] Changning Liu,et al. dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.
[14] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[15] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[16] Lynne T. Bemis,et al. Truncation in CCND 1 mRNA alters miR-16-1 regulation in mantle cell lymphoma , 2008 .
[17] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[18] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[19] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[20] Jun Zhang,et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21 , 2016, Cancer biology & therapy.
[21] Cheng Liang,et al. A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..
[22] William A Robinson,et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.
[23] T. Kwok,et al. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.
[24] Lei Wang,et al. BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..
[25] L. Lefebvre,et al. Brains, Lifestyles and Cognition: Are There General Trends? , 2008, Brain, Behavior and Evolution.
[26] Keqin Li,et al. Network Consistency Projection for Human miRNA-Disease Associations Inference , 2016, Scientific Reports.
[27] R. Vyzula,et al. Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.
[28] G. Bhanot,et al. Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.
[29] Peter S Linsley,et al. MicroRNAs and Cell Cycle Regulation , 2007, Cell cycle.
[30] C. Pasquier,et al. Prediction of miRNA-disease associations with a vector space model , 2016, Scientific Reports.
[31] Hailin Chen,et al. Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.
[32] C. Yanofsky. Establishing the Triplet Nature of the Genetic Code , 2007, Cell.
[33] Vildan Bozok Çetintaş,et al. miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells , 2016, Tumor Biology.
[34] Yan Zhao,et al. ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction , 2018, RNA biology.
[35] T. Kwok,et al. The miR-18 a microRNA functions as a potential tumor suppressor by targeting on KRas , 2009 .
[36] Ming Sun,et al. Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression , 2014, Molecular Cancer Therapeutics.
[37] Yan Zhang,et al. Prediction of Disease-related microRNAs through Integrating Attributes of microRNA Nodes and Multiple Kinds of Connecting Edges , 2019, Molecules.
[38] Jing Wang,et al. Progress in the application of molecular biomarkers in gliomas. , 2015, Biochemical and biophysical research communications.
[39] Yu Li,et al. MicroRNAs in Common Human Diseases , 2012, Genom. Proteom. Bioinform..
[40] George M Yousef,et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. , 2010, Clinical biochemistry.
[41] Martin Reczko,et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs , 2012, Nucleic Acids Res..
[42] Xing Chen,et al. Ensemble of decision tree reveals potential miRNA-disease associations , 2019, PLoS Comput. Biol..
[43] V. Ambros. MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.
[44] Yadong Wang,et al. Predicting human microRNA-disease associations based on support vector machine , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[45] Helen Wheeler,et al. Antiangiogenic therapy for high-grade glioma. , 2014, The Cochrane database of systematic reviews.
[46] Xing Chen,et al. LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..
[47] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[48] K. Mimori,et al. Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.
[49] Yun Xiao,et al. Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.
[50] Hailin Chen,et al. Prediction of Associations between OMIM Diseases and MicroRNAs by Random Walk on OMIM Disease Similarity Network , 2013, TheScientificWorldJournal.
[51] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.